Literature DB >> 1787538

Induction of anti-myelin antibodies in EAE and their possible role in demyelination.

R H Sadler1, M A Sommer, L S Forno, M E Smith.   

Abstract

Experimental allergic encephalomyelitis is characterized by invasion of lymphocytes and macrophages into the central nervous system resulting in inflammation, edema, and demyelination. Sera from Lewis rats from 7-95 days after immunization with purified guinea pig CNS myelin were examined with respect to their ability to opsonize myelin. This was correlated with the appearance of antibody components and the relative amounts of antibody to myelin basic protein (MBP) and proteolipid protein (PLP). Sera from rats 10-95 days after immunization preincubated with purified myelin induced phagocytosis of myelin by cultured macrophages with the resulting production of cholesterol ester. This opsonization activity as measured by the percentage of cholesterol esterified reached a peak at 26-27 days after immunization but remained significantly elevated up to 95 days post-immunization compared to the activity of serum from the Freund's adjuvant-injected controls. Immunoblots of the sera revealed a gradual increase in antibody activity against myelin components. ELISA assays for MBP and PLP antibody showed a similar pattern. Antibody to galactocerebroside (GC) was not detected by immunostains nor by the ELISA assay. Areas of demyelination were observed histologically by luxol-fast blue stained spinal cords up to 60 days post-immunization. These results indicate that antibodies to myelin protein when given access to myelin through or within the blood brain barrier could initiate or enhance the phagocytic response by peripheral or resident macrophages.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787538     DOI: 10.1002/jnr.490300404

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Chronic remitting experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis.

Authors:  E Zapryanova; D Deleva; M Bakalska; N Filchev
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

Review 2.  Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Anne H Cross; Jennifer L Stark
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  A role for complement in phagocytosis of myelin.

Authors:  B A DeJong; M E Smith
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 5.  Phagocytosis of myelin in demyelinative disease: a review.

Authors:  M E Smith
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 6.  The physiology of foamy phagocytes in multiple sclerosis.

Authors:  Elien Grajchen; Jerome J A Hendriks; Jeroen F J Bogie
Journal:  Acta Neuropathol Commun       Date:  2018-11-19       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.